MBAI Expands HealthTech AI Platform For Leading Derm Group MedBright AI Investments Inc. (Ticker: MBAI.c or MBAIF for US investors), a leading capital allocator in healthcare technology, recently shared that it is expanding its innovative MedMatrix AI platform in collaboration with Rejuvenation, a distinguished dermatology group renowned for advanced dermatological care.
Not only does this display MBAI's ability to make strong partnerships with distinguished medical groups but also the scalability and rapid deployment capabilities of the MedMatrix platform.
Despite MBAI's market capitalization standing at less than $20 million, the company has successfully secured agreements with 14 clinics within a span of just two months, which includes Rejuvenation as well as a clinic group affiliated with the Yale School of Medicine.
Rejuvenation, with a network spanning 8 clinics across 3 provinces in Canada, has been a pivotal player in dermatology for over four decades. Boasting a team of 21 dermatologists, 5 Mohs surgeons, 2 plastic surgeons, and 13 general practitioners, Rejuvenation has consistently delivered top-notch medical, surgical, cosmetic, and laser treatments.
Now, with the integration of MedMatrix into their operations, Rejuvenation is set to elevate its capabilities in cosmetic marketing and clinical trial analytics.
The expansion of MedMatrix into cosmetic marketing aligns with Rejuvenation's commitment to providing personalized and advanced care. The new tool will empower Rejuvenation to identify ideal candidates for cosmetic treatments, ensuring tailored recommendations for improved patient experiences and optimal treatment outcomes.
Moreover, MedMatrix's clinical trial recruitment tools will enable Rejuvenation to swiftly assess patient eligibility for clinical trials. This not only enhances patient access to cutting-edge treatments but also streamlines the recruitment process for Rejuvenation's partners, contributing to the advancement of medical research and innovation.
Trevor Vieweg, CEO of MedBright AI, expressed enthusiasm about the collaboration, stating, "Combining the power of MedMatrix with the large patient base of Rejuvenation is set to provide new opportunities for Rejuvenation and improve the patient experience for their customers."
MBAIs strategic focus on healthcare technology investments and its mission to construct a synergistic portfolio align seamlessly with Rejuvenation's dedication to excellence.
Together, they aim to harness the potential of AI in healthcare to enhance patient care, drive innovation, and create value for shareholders.
Full news here: https://www.medbright.ai/blog-posts/medbright-ais-medmatrix-to-expand-its-ai-offerings-for-cosmetic-marketing-clinical-trial-analytics
Posted on behalf of Medbright AI Investments Inc.